ICMS/SKLQRCM Distinguished Guest Seminar Series (2024-005): ‘Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathway’ by Prof. Yunyan GU from Harbin Medical University